TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1289101

Group type: EXPERIMENTAL
Intervention: Alteplase (tPA)
Number of subjects: 20891

Group type: COMPARATOR
Intervention: Streptokinase (SK)
Number of subjects: 20891

Group type: EXPERIMENTAL
Intervention: Heparin
Number of subjects: 20891

Group type: COMPARATOR
Intervention: No Heparin
Number of subjects: 20891

Group type: EXPERIMENTAL
Intervention: SK plus Heparin
Number of subjects: 20891
Study: 3905057

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy
Number of subjects: 780

Group type: EXPERIMENTAL
Intervention: Surgical therapy with exercise-induced angina
Number of subjects: 780

Group type: COMPARATOR
Intervention: Medical therapy with exercise-induced angina
Number of subjects: 780
Study: 30946974

Group type: EXPERIMENTAL
Intervention: Brief psychosocial intervention
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy
Number of subjects: 406

Group type: EXPERIMENTAL
Intervention: Short-term psychoanalytic psychotherapy
Number of subjects: 406

Group type: COMPARATOR
Intervention: Dropouts (no specific intervention)
Number of subjects: 406
Study: 29872997

Group type: EXPERIMENTAL
Intervention: Running on a treadmill
Number of subjects: 24

Group type: COMPARATOR
Intervention: Watching a video
Number of subjects: 24
Study: 26663710

Group type: EXPERIMENTAL
Intervention: 3DCRT/IMRT
Number of subjects: 254

Group type: COMPARATOR
Intervention: 2DRT
Number of subjects: 254
Study: 25174776

Group type: EXPERIMENTAL
Intervention: iopromide 370 mgI/mL
Number of subjects: 144

Group type: COMPARATOR
Intervention: iopromide 300 mgI/mL
Number of subjects: 144
Study: 22884306

Group type: EXPERIMENTAL
Intervention: Family focused treatment for adolescents (FFT‐A)
Number of subjects: 53

Group type: COMPARATOR
Intervention: Enhanced care (a briefer psychoeducational treatment)
Number of subjects: 53
Study: 20179283

Group type: EXPERIMENTAL
Intervention: ScvO2 group (resuscitated to normalize central venous pressure, mean arterial pressure, and ScvO2 of at least 70%)
Number of subjects: 300

Group type: COMPARATOR
Intervention: Lactate clearance group (resuscitated to normalize central venous pressure, mean arterial pressure, and lactate clearance of at least 10%)
Number of subjects: 300
Study: 17414228

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study: 15623998

Group type: EXPERIMENTAL
Intervention: Amalgam (Megalloy)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Bonding agent (Syntac) with amalgam
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Amalgam with adhesive resin luting agent (Resinomer)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (not restored)
Number of subjects: 40
Study: 11850771

Group type: EXPERIMENTAL
Intervention: Losartan
Number of subjects: 50

Group type: COMPARATOR
Intervention: Enalapril
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 50
Study: 10610086

Group type: EXPERIMENTAL
Intervention: Health and nutrition intervention in 24 schools over six years
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group of 16 schools
Number of subjects: 40
Study: 7626876

Group type: EXPERIMENTAL
Intervention: Warm blood cardioplegia with continuous ante‐retrograde combined delivery during normothermic CPB
Number of subjects: 100

Group type: COMPARATOR
Intervention: Cold blood intermittent cardioplegia plus topical ice slush in hypothermic CPB
Number of subjects: 100
Study: 2275323

Group type: EXPERIMENTAL
Intervention: Propofol (PPF)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Midazolam (MDZ)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Midazolam (MDZ) with Flumazenil (FMZ)
Number of subjects: 30
Study: 7356904

Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Promethazine plus codeine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Codeine in smokers
Number of subjects: 0
Study: 31443226

Group type: EXPERIMENTAL
Intervention: Highest quartile of dietary acid load
Number of subjects: 3042

Group type: COMPARATOR
Intervention: Lowest quartile of dietary acid load
Number of subjects: 3042
Study: 28106665

Group type: EXPERIMENTAL
Intervention: Renal denervation (RDN)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 17
Study: 25471205

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Early PCI (within 2 weeks after last ischemic episode)
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Preprocedural variables
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Procedural variables
Number of subjects: 104

Group type: EXPERIMENTAL
Intervention: Lesion characteristics
Number of subjects: 104
Study: 25062336

Group type: EXPERIMENTAL
Intervention: prednisolone acetate 1%
Number of subjects: 325

Group type: COMPARATOR
Intervention: fluorometholone 0.1%
Number of subjects: 325
Study: 22500578

Group type: EXPERIMENTAL
Intervention: Maxillary advancement
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Mandibular set back
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Bimaxillary surgery
Number of subjects: 48
Study: 20025372

Group type: EXPERIMENTAL
Intervention: Brief mindfulness-based instructions
Number of subjects: 123

Group type: COMPARATOR
Intervention: No-instruction control group
Number of subjects: 123
Study: 17336181

Group type: EXPERIMENTAL
Intervention: Recombinant human epidermal growth factor 1‐48 (EGF(1‐48)) at 100 ng kg(‐1) h(‐1) for 6 days
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 15181565

Group type: EXPERIMENTAL
Intervention: rIFN-gamma 1b (100 microg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: rIFN-gamma 1b (200 microg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: rIFN-gamma 1b (100 microg) and rIFN-gamma 1b (200 microg) combined
Number of subjects: 75
Study: 11352127

Group type: EXPERIMENTAL
Intervention: Postmenopausal hormone replacement therapy (HRT)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 96
Study: 9609431

Group type: EXPERIMENTAL
Intervention: Premedication with pronase
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dimethylpolysiloxane alone
Number of subjects: 100

Group type: COMPARATOR
Intervention: Dimethylpolysiloxane plus sodium bicarbonate
Number of subjects: 100
Study: 11644558

Group type: EXPERIMENTAL
Intervention: Randomised controlled trial treatment protocol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Randomised controlled trial
Number of subjects: 0
Study: 2187486

Group type: EXPERIMENTAL
Intervention: Methylprednisolone
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 88984

Group type: EXPERIMENTAL
Intervention: Phenoxybenzamine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31253234

Group type: EXPERIMENTAL
Intervention: Trials that reported results by sex or gender
Number of subjects: 45

Group type: COMPARATOR
Intervention: Trials that did not report results by sex or gender
Number of subjects: 45
Study: 26838769

Group type: EXPERIMENTAL
Intervention: 12-week low-caloric diet (intense weight loss)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Weight maintenance (4 weeks after initial weight loss)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Control group (n = 18)
Number of subjects: 19
Study: 26132586

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Laparoscopic adjustable gastric banding (LAGB)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Intensive lifestyle weight loss intervention
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: RYGB
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: LAGB
Number of subjects: 61
Study: 23322462

Group type: COMPARATOR
Intervention: Bilateral controlled shoes with no insoles
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Lateral wedge insoles laterally posted by 5°
Number of subjects: 51
Study: 20607425

Group type: EXPERIMENTAL
Intervention: Auto-adjusting bi-level mode (VAuto™)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Standard bi-level mode
Number of subjects: 22
Study: 19231043

Group type: EXPERIMENTAL
Intervention: Alpha-lipoic acid (ALA) 200 mg
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 60
Study: 16768834

Group type: EXPERIMENTAL
Intervention: Soya isoflavones (50 mg/d)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 15815568

Group type: EXPERIMENTAL
Intervention: Education (ED)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Education and telephone case management (ED + TCM)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Standard care (SC)
Number of subjects: 75
Study: 12963609

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid supplementation (400 mg/d)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid supplementation
Number of subjects: 44
Study: 10693491

Group type: EXPERIMENTAL
Intervention: Evidence-based nursing
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Randomized controlled trial (RCT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quasi-legal model based on reflection
Number of subjects: 0
Study: 7588509

Group type: EXPERIMENTAL
Intervention: High-fibre diet (rye bran bread and whole-grain rye crispbread)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Low-fibre diet (wheat-flour bread)
Number of subjects: 8
Study: 2137233

Group type: EXPERIMENTAL
Intervention: Rimantadine hydrochloride (RH)
Number of subjects: 301

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 301
Study: 6446442

Group type: COMPARATOR
Intervention: DMPA
Number of subjects: 239

Group type: EXPERIMENTAL
Intervention: NET-ENT
Number of subjects: 239
Study: 12086759

Group type: EXPERIMENTAL
Intervention: High-dose BEAM and transplantation of haemopoietic stem cells (BEAM‐HSCT)
Number of subjects: 161

Group type: COMPARATOR
Intervention: Dexa‐BEAM (dexamethasone and carmustine, etoposide, cytarabine, and melphalan)
Number of subjects: 161

Group type: EXPERIMENTAL
Intervention: Overall survival for both treatments
Number of subjects: 161
Study: 31899499

Group type: EXPERIMENTAL
Intervention: Home exercise intervention delivered by a physical therapist with 6 home visits over 8 months and monthly calls, exercising ≥3 times weekly
Number of subjects: 141

Group type: COMPARATOR
Intervention: Attentional control group receiving equal attention
Number of subjects: 141
Study: 29667763

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg
Number of subjects: 117

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 117

Group type: EXPERIMENTAL
Intervention: Dutasteride 0.5 mg (open-label)
Number of subjects: 117
Study: 27439911

Group type: EXPERIMENTAL
Intervention: Carfilzomib, lenalidomide, and dexamethasone (KRd)
Number of subjects: 792

Group type: COMPARATOR
Intervention: Lenalidomide and dexamethasone (Rd)
Number of subjects: 792
Study: 24906519

Group type: EXPERIMENTAL
Intervention: Computer-assisted TKA (group NAV)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Conventional TKA (group REG)
Number of subjects: 200
Study: 22241704

Group type: EXPERIMENTAL
Intervention: Home-based constraint-induced therapy
Number of subjects: 22

Group type: COMPARATOR
Intervention: Traditional rehabilitation
Number of subjects: 22
Study: 20937130

Group type: EXPERIMENTAL
Intervention: NGX-4010 (8% capsaicin patch)
Number of subjects: 155

Group type: COMPARATOR
Intervention: 0.04% capsaicin control patch
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: NGX-4010 (8% capsaicin patch) in patients with PHN for at least 6 months
Number of subjects: 155

Group type: COMPARATOR
Intervention: 0.04% capsaicin control patch in patients with PHN for at least 6 months
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: NGX-4010 (8% capsaicin patch) at week 12 in patients with PHN for at least 6 months
Number of subjects: 155

Group type: COMPARATOR
Intervention: 0.04% capsaicin control patch at week 12 in patients with PHN for at least 6 months
Number of subjects: 155
Study: 18824909

Group type: EXPERIMENTAL
Intervention: Systematic approach to weaning and extubation
Number of subjects: 318

Group type: COMPARATOR
Intervention: Sole physician's judgment (control)
Number of subjects: 318
Study: 16093411

Group type: EXPERIMENTAL
Intervention: Auditory stimuli
Number of subjects: 59

Group type: COMPARATOR
Intervention: Visual stimuli
Number of subjects: 59

Group type: COMPARATOR
Intervention: Cross-modal visual-auditory stimuli
Number of subjects: 59
Study: 12057791

Group type: EXPERIMENTAL
Intervention: Slip-Coat cannula
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard cannula
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Slip-Coat cannula (for women with no prior live births)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standard cannula (for women with no prior live births)
Number of subjects: 50
Study: 9932855

Group type: EXPERIMENTAL
Intervention: Cisapride 0.3 mg/kg four times a day for 8 weeks
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 7551831

Group type: EXPERIMENTAL
Intervention: Pivmecillinam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Norfloxacin
Number of subjects: 0
Study: 1969196

Group type: EXPERIMENTAL
Intervention: Local analgesics (lignocaine)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Topical analgesic cream (EMLA)
Number of subjects: 0
Study: 7451917

Group type: EXPERIMENTAL
Intervention: Single extraamniotic dose of F2-alpha prostaglandin gel
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 0
Study: 31985294

Group type: EXPERIMENTAL
Intervention: CinnoRA® (40 mg subcutaneous injection)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Humira® (40 mg subcutaneous injection)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: CinnoRA®
Number of subjects: 74

Group type: COMPARATOR
Intervention: Humira®
Number of subjects: 74
Study: 31060602

Group type: EXPERIMENTAL
Intervention: Durvalumab
Number of subjects: 163

Group type: COMPARATOR
Intervention: High density of CD8+ cells in non-ICT patients
Number of subjects: 163
Study: 27794137

Group type: EXPERIMENTAL
Intervention: Prolonged sitting with intermittent walking
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Prolonged sitting with intermittent standing exercises
Number of subjects: 19

Group type: COMPARATOR
Intervention: Uninterrupted sitting
Number of subjects: 19
Study: 26036466

Group type: EXPERIMENTAL
Intervention: S-1 daily administration (Arm A)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: S-1 alternate-day administration (Arm B)
Number of subjects: 0
Study: 24184429

Group type: EXPERIMENTAL
Intervention: sertraline at standard dosing + CBT
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: sertraline titrated slowly + CBT
Number of subjects: 47

Group type: COMPARATOR
Intervention: pill placebo + CBT
Number of subjects: 47
Study: 21615714

Group type: EXPERIMENTAL
Intervention: Digital placement of Foley catheter
Number of subjects: 42

Group type: COMPARATOR
Intervention: Speculum placement of Foley catheter
Number of subjects: 42
Study: 19293796

Group type: EXPERIMENTAL
Intervention: Screening with PSA
Number of subjects: 43842

Group type: EXPERIMENTAL
Intervention: Screening with PSA (excluding overdiagnosed cases)
Number of subjects: 43842
Study: 16674782

Group type: EXPERIMENTAL
Intervention: Partnership care model intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 0
Study: 14656837

Group type: EXPERIMENTAL
Intervention: Automated external defibrillator (AED) use by first responders
Number of subjects: 469

Group type: COMPARATOR
Intervention: Control group (no AED use)
Number of subjects: 469
Study: 10699684

Group type: EXPERIMENTAL
Intervention: Minimization method for random allocation of patients
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Zelen's method for randomization
Number of subjects: 13
Study: 8852869

Group type: EXPERIMENTAL
Intervention: Intravenous sodium lactate infusions
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo infusions
Number of subjects: 9
Study: 2049259

Group type: EXPERIMENTAL
Intervention: Cimetidine (300 mg four times daily)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ranitidine (150 mg twice daily)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Cifenline alone (160 mg)
Number of subjects: 12
Study: 6363798

Group type: EXPERIMENTAL
Intervention: Indomethacin, 25 mg four times daily for 3 weeks
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 24
Study: 31512500

Group type: EXPERIMENTAL
Intervention: Devimistat (2000 mg/m2) in combination with high dose cytarabine and mitoxantrone
Number of subjects: 0

Group type: COMPARATOR
Intervention: High dose cytarabine and mitoxantrone alone
Number of subjects: 0
Study: 27826107

Group type: EXPERIMENTAL
Intervention: dual-tDCS
Number of subjects: 22

Group type: COMPARATOR
Intervention: sham
Number of subjects: 22
Study: 24584609

Group type: EXPERIMENTAL
Intervention: Automated Peritoneal Dialysis (APD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Continuous Ambulatory Peritoneal Dialysis (CAPD)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Comparison of total clearance and mass removal (MR)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Protein-bound solutes
Number of subjects: 15
Study: 23031656

Group type: EXPERIMENTAL
Intervention: Codeine
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Meloxicam
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Nimesulide
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Benzydamine
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Rofecoxib
Number of subjects: 1071

Group type: COMPARATOR
Intervention: Paracetamol
Number of subjects: 1071
Study: 21792073

Group type: EXPERIMENTAL
Intervention: Quantitative real-time polymerase chain reaction-based assay using a predictor of survival from 91 genes
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Quantitative real-time polymerase chain reaction-based assay for stage 1 patients
Number of subjects: 101
Study: 19451554

Group type: EXPERIMENTAL
Intervention: Candesartan, 16 mg/d increasing to 32 mg/d
Number of subjects: 5221

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5221
Study: 16945857

Group type: EXPERIMENTAL
Intervention: Intentional learning condition (searching for the underlying rule with feedback)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Incidental learning condition (memorizing a set of grammatical tunes)
Number of subjects: 0
Study: 15560811

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivatives (EMD) applied in test subjects
Number of subjects: 172

Group type: COMPARATOR
Intervention: No EMD applied in control subjects
Number of subjects: 172

Group type: EXPERIMENTAL
Intervention: EMD applied in test subjects
Number of subjects: 172

Group type: COMPARATOR
Intervention: Both EMD and no EMD
Number of subjects: 172
Study: 11742907

Group type: EXPERIMENTAL
Intervention: Hypertonic saline solution (4.5%) inhalation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Isotonic saline solution (0.9%) inhalation
Number of subjects: 16
Study: 9602598

Group type: EXPERIMENTAL
Intervention: Cuffed oropharyngeal airway (COPA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Tracheal tube (TT)
Number of subjects: 20
Study: 7973107

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (5 mg) given 4 times daily for 24 hours on 2 consecutive days
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline given 4 times daily for 24 hours on 2 consecutive days
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Nebulised salbutamol (5 mg)
Number of subjects: 22
Study: 2659302

Group type: EXPERIMENTAL
Intervention: Sucrose-containing snacks (7% of total daily calories)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Aspartame-sweetened snacks (1% of total daily calories)
Number of subjects: 16
Study: 30980248

Group type: EXPERIMENTAL
Intervention: Non-daily smokers
Number of subjects: 1916
Study: 29354957

Group type: EXPERIMENTAL
Intervention: Fire needle plus chemotherapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Chemotherapy alone
Number of subjects: 60
Study: 26145718

Group type: EXPERIMENTAL
Intervention: Chiropractic SMT
Number of subjects: 70

Group type: COMPARATOR
Intervention: Placebo (sham manipulation)
Number of subjects: 70
Study: 23273236

Group type: EXPERIMENTAL
Intervention: Health education program
Number of subjects: 153

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 153
Study: 21247529

Group type: EXPERIMENTAL
Intervention: MLN1202
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 18271771

Group type: EXPERIMENTAL
Intervention: Topical therapy with 0.2% minocycline
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo aqueous solution mouthwash
Number of subjects: 33
Study: 17071204

Group type: EXPERIMENTAL
Intervention: Ischemic preconditioning (IP group, n = 27)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Intermittent vascular occlusion (IVO group, n = 27)
Number of subjects: 54
Study: 12430110

Group type: COMPARATOR
Intervention: Single stimulation group (30 mL local anesthetic injected after locating 1 motor response)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multistimulation group (10 mL local anesthetic injected on each of 3 motor responses)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multistimulation group
Number of subjects: 80
Study: 10087113

Group type: EXPERIMENTAL
Intervention: Intravenous injection of mangafodipir trisodium (Mn‐DPDP) at a dosage of 5 micromol/kg.
Number of subjects: 18
Study: 7552592

Group type: EXPERIMENTAL
Intervention: Enteral allopurinol (20 mg/ml) for seven daily doses
Number of subjects: 400

Group type: COMPARATOR
Intervention: Placebo (equivalent dose) for seven daily doses
Number of subjects: 400

Group type: EXPERIMENTAL
Intervention: Enteral allopurinol (20 mg/ml)
Number of subjects: 400
Study: 2210808

Group type: EXPERIMENTAL
Intervention: 200 mmol sodium chloride added to a low salt diet (20 mmol NaCl/day) for 1 week
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Sodium citrate (200 mmol sodium/day) as a supplement to the low salt diet for a third week
Number of subjects: 40

Group type: COMPARATOR
Intervention: Low salt diet (20 mmol NaCl/day)
Number of subjects: 40